附件99.1

祁連國際控股集團有限公司宣佈向股東派發特別現金股息

酒泉，中國，2023年2月16日/美通社/ --祁連國際控股集團有限公司，一家總部位於中國的醫藥和化工產品製造商今天宣佈，公司已宣佈派發每股普通股0.05美元的特別一次性現金股息，於2023年3月6日左右以現金形式支付給2023年2月28日登記在冊的股東。

公司首席執行官陳佔昌表示：“儘管新冠肺炎在上一財年對我們造成了影響，但公司仍保持了良好的經營業績和健康的現金流。隨着中國宣佈取消抗擊新冠病毒措施，我們預計會有更好的財務業績。”

關於祁連國際控股集團有限公司

祁連國際控股集團有限公司，總部設在甘肅，中國，是中國的一家醫藥化工產品製造商。專注於甘草產品、土黴素產品、中藥衍生品、肝素產品、香腸腸衣、化肥的開發、製造、營銷和銷售。本公司產品遠銷全國20多個省、市、自治區、自治區、直轄市。欲瞭解更多信息，請訪問公司網站：http://ir.qlsyy.net.

前瞻性陳述

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; products demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China; the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.